Cerebral Arteriovenous Malformation
A congenital tangle of abnormal brain blood vessels causing direct artery-to-vein connections, carrying a high risk of spontaneous intracranial hemorrhage or new-onset seizures.
Emergency Management: Acute AVM rupture with massive intracranial hemorrhage requiring intubation, emergency craniotomy/decompressive hemicraniectomy, and intensive care management.
A cerebral arteriovenous malformation (AVM) is a complex, tangled web of abnormal blood vessels in the brain where arteries connect directly to veins without an intervening capillary bed. This structurally anomalous network, termed the nidus, shunts high-pressure arterial blood directly into the venous system, bypassing normal brain tissue and significantly increasing the risk of vessel rupture and intracranial hemorrhage.
Detailed Overview
Cerebral AVMs are usually congenital lesions, though they often remain clinically silent until adulthood. The lack of a capillary bed causes low vascular resistance, creating a high-flow arteriovenous shunt. The high arterial pressure transmitted directly to thin-walled veins leads to venous engorgement, aneurysmal dilation, and potential rupture. Hemorrhage is the most devastating complication, occurring in roughly 2-4% of untreated AVMs annually. Other presentations include seizures (often focal) due to local cortical irritation or steal phenomenon, where blood is diverted from adjacent healthy brain tissue causing progressive ischemia.
Epidemiology & Demographics
Prevalence is estimated at 10-18 per 100,000 population. Hemorrhages typically peak between 20 and 40 years of age. There is a slight male predominance or equal gender distribution. Account for 1-2% of all strokes, but a much higher percentage of hemorrhagic strokes in young adults.
Etiological Mechanism
Considered to be congenital developmental anomalies occurring during early embryonic angiogenesis (between the 3rd and 8th weeks of gestation). Most are sporadic, though a small minority are associated with hereditary hemorrhagic telangiectasia (HHT/Osler-Weber-Rendu syndrome).
Primary Causes
Dysregulation of vascular endothelial growth factors (VEGF) and angiopoietins during fetal brain development. Somatic mutations in the KRAS signaling pathway have been recently identified in sporadic AVM tissue.
The core of the AVM is the nidus. Due to the absence of capillaries, the resistance across the nidus is abnormally low. Arterial feeding vessels dilate due to increased flow demand, and draining veins become tortuous, thick-walled, and frequently develop pseudoaneurysms due to exposure to systemic arterial pressures. Surrounding brain tissue may suffer from hypoperfusion (vascular steal) leading to gliosis, which acts as a seizure focus. High-pressure venous drainage can also impede normal venous drainage of adjacent brain, causing venous hypertension and edema.
Diagnostic Criteria & Guidelines
Diagnosis is established by neuroimaging demonstrating a nidus of tangled blood vessels with early venous filling on angiography.
For acutely ruptured AVMs: stabilization of airway and hemodynamics, reversal of anticoagulation, and management of elevated ICP (e.g., Mannitol, hypertonic saline, external ventricular drain). Definitive treatment of the AVM involves a multidisciplinary approach based on Spetzler-Martin grade. Microsurgical resection is first-line for superficial, easily accessible AVMs (Grade I-II), offering immediate cure. Endovascular embolization (using agents like Onyx or n-BCA) is often used pre-operatively to reduce blood flow and surgical risk.
Second-Line & Adjunctive Therapy
Stereotactic Radiosurgery (e.g., Gamma Knife) is preferred for small (<3 cm), deep-seated, or eloquently located AVMs where open surgery carries high risk. It induces vessel endothelial proliferation and thrombosis over 2-3 years, during which the patient remains at risk for hemorrhage. For Spetzler-Martin Grade IV-V unruptured AVMs, conservative medical management (blood pressure control, anticonvulsants) is often favored over intervention due to unacceptably high treatment morbidity (based on ARUBA trial data).
Surgical & Procedural Management
Microsurgical craniotomy for block resection of the nidus. Involves isolating and coagulating arterial feeders followed by en bloc removal of the nidus, and finally transecting the draining vein.
Patient Counseling & Advice
Educate on the signs of acute hemorrhage (sudden extreme headache, weakness) indicating the need to call 911 immediately. Discuss that radiosurgery takes up to 3 years to obliterate the AVM, requiring patience and lifestyle modifications in the interim.
Follow-Up & Monitoring Schedule
Annual MRI/MRA for patients managed conservatively or undergoing radiosurgery. Follow-up DSA 1-3 years post-treatment to confirm complete angiographic obliteration.
Preventive Strategies
No primary prevention available as it is a congenital anomaly. Secondary prevention of rupture involves stringent blood pressure management.
Untreated, the annual rupture risk is roughly 2-4%, with each hemorrhage carrying a 10-15% mortality and 30-50% morbidity rate. Surgical cure eliminates the risk of future hemorrhage.